UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 20, 2007

PSS WORLD MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

Commission File Number: 0-23832

Florida	59-2280364
(State or other jurisdiction	(IRS Employer
of incorporation or organization)	Identification Number)
4345 Southpoint Blvd.
Jacksonville, Florida	32216
(Address of principal executive offices)	(Zip code)
Registrant’s telephone number, including area code	(904) 332-3000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Compensation of Executive Officers

On August 20, 2007, the Compensation Committee of the Board of Directors approved the following increases in annual base salary for certain of the executive officers as described in the table below:

Name	Executive Position	Fiscal Year 2008 Base Salary
David A. Smith	Chairman and Chief Executive Officer	$	755,000
David M. Bronson	Executive Vice President and Chief Financial Officer	$	360,000
Gary A. Corless	Executive Vice President and Chief Operating Officer	$	422,000
John F. Sasen, Sr.	Executive Vice President and Chief Marketing Officer	$	333,000
Bradley J. Hilton	Senior Vice President of Operations	$	250,000

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 20, 2007

PSS WORLD MEDICAL, INC.
By:	/s/ David M. Bronson
	Name: David M. Bronson Title: Executive Vice President and Chief Financial Officer